SCHEMBL7982337

SCHEMBL7982337

c1ccc(Nn2cncn2)cc1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 3/20 0.44
CYP19A1 P11511 5/20 0.41
ALDH1A1 P00352 2/20 0.40
GAA P10253 1/20 0.40
HSP90AA1 P07900 1/20 0.36
CYP1A2 P05177 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
CTSD P07339 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MAPK10 P53779 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2699301 0.76 CYP19A1 (0.49) CYP19A1CYP3A4CYP2C19
SCHEMBL2701279 0.73 ALDH1A1 (0.44) CYP19A1ALDH1A1HSP90AA1SMN1; SMN2HSD17B10
SCHEMBL9821437 0.71 CYP19A1 (0.50) CYP26A1CYP19A1ALDH1A1GAAHSP90AA1
SCHEMBL825684 0.70 CYP1A2 (0.38) CYP26A1CYP19A1ALDH1A1GAACYP1A2
SCHEMBL6663174 0.68 ALDH1A1 (0.53) ALDH1A1GAASMN1; SMN2CYP3A4CYP2C9
Diphenylamine SCHEMBL19347159 0.68 CYP26A1 (0.53) CYP26A1CYP19A1ALDH1A1CYP1A2CYP3A4
SCHEMBL1118125 0.67 NOTUM (0.45) ALDH1A1CYP1A2SMN1; SMN2CTSDTDP1
SCHEMBL5114471 0.66 MAPK10 (0.53) CYP26A1CYP19A1ALDH1A1HSP90AA1CYP1A2
SCHEMBL23875581 0.64 CYP19A1 (0.51) CYP19A1ALDH1A1HSP90AA1SMN1; SMN2TDP1
SCHEMBL6445730 0.64 CYP1A2 (0.40) CYP19A1ALDH1A1GAACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001087845-A2 N-CONTAINING HETEROCYCLIC COMPOUNDS AND THEIR USE AS 5-HT ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-22 WO disclosed